Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase IV prospective, randomized, open label, comparative, multicenter study in
generally healthy postmenopausal women receiving Totelle (17B Estradiol/TMG CC (1mg)) and
Livial (Tibolone).